Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,840
Closed -$533K 1990
2024
Q1
$533K Sell
6,840
-225
-3% -$16.7K 0.01% 1231
2023
Q4
$505K Buy
7,065
+38
+0.5% +$2.65K 0.01% 1205
2023
Q3
$488K Sell
7,027
-3,650
-34% -$276K 0.01% 1141
2023
Q2
$865K Buy
10,677
+3,851
+56% +$315K 0.01% 908
2023
Q1
$551K Buy
+6,826
New +$550K 0.01% 1074
2022
Q4
Sell
-4,503
Closed -$291K 1831
2022
Q3
$291K Buy
4,503
+954
+27% +$66.1K 0.01% 1315
2022
Q2
$246K Buy
+3,549
New +$263K ﹤0.01% 1325

Other funds holding HOLX

Atria Wealth Solutions's HOLX Position: Q2 2024 in Review

Atria Wealth Solutions sold out of Hologic (HOLX) in Q2 2024, closing a stake of 6,840 shares — an estimated $533K sold.

Atria Wealth Solutions first reported a position in HOLX in Q2 2022 and held it in 7 quarters. The position peaked at $865K in Q2 2023. 702 funds tracked by Wall St. Rank hold HOLX as of Q2 2024.

  • Atria Wealth Solutions reported no remaining Hologic position as of Q2 2024 after selling out during the quarter.
  • Atria Wealth Solutions sold 6,840 Hologic shares in Q2 2024, an estimated $533K.
  • Atria Wealth Solutions first reported a position in Hologic in Q2 2022 and held it in 7 quarters.
  • Atria Wealth Solutions's Hologic position peaked at $865K in Q2 2023.
  • 702 funds tracked by Wall St. Rank held Hologic as of Q2 2024.

Based on Atria Wealth Solutions's 13F filing for Q2 2024, filed 22 Jul 2024.